Moreover, our study found that in NSCLC patients with normal baseline QTc who underwent first- and third-generation EGFR-TKI sequentially, third-generation EGFR-TKI induced more significant top-QTc prolongation. This evidence concerns the gene EGFR and non-small cell lung carcinoma.